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Abstract Approximately 10% of patients with AIDS
present with some neurological deficit as their initial
complaint, and up to 80% will have CNS involvement
during the course of their disease. Toxoplasmosis is the
most common cause of cerebral mass lesions in patients
with AIDS, but appears to be an uncommon cause of
spinal cord disease. The incidence of myelopathy may
be as high as 20%, with 50% of the cases reported post-
mortem. We present a unique case of spinal cord
disease as the initial presentation of AIDS. We also
present a comprehensive literature review of this topic,
its diagnosis and treatment. This is a retrospective chart
review case report. After a detailed case presentation,
several diagnostic and therapeutic aspects of this unique
case are thoroughly discussed. Although spinal cord
toxoplasmosis is uncommon, it has been suggested that
most patients with AIDS that present with evolving
myelopathy, characterized by extremity weakness, sen-
sory involvement, spinal cord enlargement, enhancing
lesions in brain or spinal cord CT or MRI, have
toxoplasmic myelitis.
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Introduction
Although spinal cord abnormalities in patients with acquired
immunodeficiency syndrome (AIDS) have been infrequently
reported in the literature, myelitis is a known complication of
AIDSandisoccasionallytheinitialcomplaint.Theincidenceof
myelopathy may be as high as 20%, with 50% of the cases
reported post-mortem [3, 5]. Toxoplasmosis is the most
common cause of intracranial lesions responsible for neuro-
logical deficits in AIDS patients, occurring in 3–10% of
patients in the United States and in up to 50% of AIDS
patients in Europe, Latin America, and Africa [6, 10]. A
review of existing literature suggests that although Toxoplas-
mic myelitis is uncommon, it should be suspected in
immunocompromised patients who present with symptoms
of acute or sub-acute myelopathy [7]. The initial evaluation
should aid in differentiating between other reported causes of
myelopathy (such as vacuolar myelopathy, lymphoma,
tuberculosis, and viral infections including cytomegalovirus
infection, herpes zoster, and herpes simplex) in AIDS
patients [2, 4]. Since 1986, 18 cases of apparent toxoplas-
mosis of the spinal cord have been described [4, 7, 11, 12].
A case report and pertinent literature were reviewed, leading
to the diagnosis and management options discussed below.
Case report
A 40-year-old Hispanic man was admitted to the hospital
after being found unconscious. He had a 2-day history of
disorientation that manifested itself as his being unable to
recognize family members. Upon admission he regained
consciousness, becoming alert and oriented, but developed
urinary retention and was unable to move or feel his lower
extremities. He had no history of systemic illness, but
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mately 3 years prior. He denied having a history of fever,
chills, nausea, vomiting, rash, seizures, or other constitu-
tional symptoms. He had not traveled recently, and his HIV
status was unknown at the time of admission.
Physical examination revealed fever, nuchal rigidity, and
a distended bladder that required catheterization. No rash,
erythema, oral lesions, lymphadenopathy, or papilledema
was noted. A neurological examination confirmed that he
had intact cranial nerves and normal upper extremity
strength. Both lower extremities exhibited flaccid paralysis
and reduced response to pain, touch, and temperature
(bilaterally from L1). There was impairment of propiocep-
tion and vibration. Cerebellar examination was normal in the
upper extremities, with an adequate finger-to-nose exam.
The patient’s WBC, hemoglobin, platelets, electrolytes,
BUN,andcreatininewerewithinnormalrangesonadmission.
The initial brain CT (without contrast) revealed a focal area of
vasogenic edema in the left frontal lobe (without significant
mass effect) and abnormal white matter hypo-density seen
along the lateral aspect of the right frontal horn of the internal
capsule. A brain MRI (with and without gadolinium enhance-
ment) revealed multiple bilateral ring-enhancing intra-axial
brain lesions, and an ill-defined cortical and sub-cortical
enhancement, with diffuse edema in the frontal lobe.
Spinal MRI (with and without gadolinium) showed the
spinal cord to be abnormally diffuse, with swelling and
edema in the cervicothoracic region. Along with the diffuse
abnormal hyperintense swelling, the cauda equina had an
edematous appearance, and signal intensity was abnormally
increased, which is compatible with transverse myelitis
(Figs. 1 and 2). Finally, imaging also revealed a focal area
of abnormal signal intensity in the ventral inferior pons.
He was initially given broad spectrum antibiotics
(ceftriaxone, vancomycin, and ampicillin) and acyclovir at
admission for a presumptive CNS infection. HIV serology
was recommended, though the patient denied ever having
engaged in high-risk behavior or having had a blood
transfusion at any time in his past. Analysis of CSF showed
abnormal values including a WBC count of 11/mm
3 and a
protein level of 184.5 mg/dl, with a glucose concentration
Fig. 1 Initial MRI: notice the abnormal spinal cord swelling cervical
and at cauda equina
Fig. 2 Normal F/U study
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fast bacilli were negative. A CSF cryptococcal antigen titer
and HTLV I/II antibody assay were negative; a VDRL test
was non-reactive. Cytology revealed pleocytosis with a
predominance of mononuclear lymphoid-like cells. An anti-
toxoplasma immunoglobulin (IgG) immune titer was
positive at 8.99 (<0.9=negative; ≥1.10=positive). At this
point, the patient disclosed having engaged in homosexual
behavior and accepted HIV testing, which was reactive by
ELISA. Empiric treatment for toxoplasmosis with sulfadia-
zine, pyrimethamine, folinic acid, and HAART therapy with
lamivudine/zidovudine and indinavir were started. Intrave-
nous dexamethasone was administered for 7 days, and oral
methylprednisolone for another week. A lymphocyte subset
panel revealed a CD4 count of 56 cells/mm
2. Positive Western
blot results arrived, confirming a diagnosis of HIV. Neither
PET nor SPECT was available for an additional imaging
workup. Biopsy was deferred due to possible complications
and the evidence of improvement with therapy.
Within 4 days of empiric treatment for toxoplasmosis, the
patient’s neck rigidity resolved. He progressively developed
discrimination to touch and his vibratory sensation im-
proved, as did his bilateral strength (1/5) of the lower
extremities. Follow-up consisted of a brain and spinal cord
MRI (with and without gadolinium), 14 days after treatment
with anti-toxoplasmosis therapy combined with steroids,
which demonstrated resolved swelling and residual T2
hyper-intensity in the mid-thoracic spinal cord, without an
interval change in the brain MRI. The patient was discharged
home with rehabilitation therapy after 22 days of admission.
Discussion
AIDS-related spinal cord disorders include neoplasms,
infections (including HIV itself), vascular disease, and other
undefined etiologies. Toxoplasmosis and lymphoma are the
two most common intracranial lesions, and both have been
reported in increasing frequency in the spinal cord [1].
Myelopathy is usually under-diagnosed, probably because
of the occurrence of coexisting conditions such as AIDS
dementia complex (ADC), cerebral lesions of varying
etiologies, vacuolar myelopathy, lumbosacral myelopathy,
or peripheral neuropathy that may mask the clinical signs
suggestive of myelopathy [5, 9, 10]. Other causes of
myelopathy appear to be less common than toxoplasmosis
and include tuberculoma, cytomegalovirus, varicella-zoster
virus, and, possibly, lymphoma [4, 10]. Postmortem
histopathology examination has resulted in a definitive
diagnosis of myelopathy in the majority of patients [7].
Spinal cord lesions often manifest with a variety of
symptoms, such as leg weakness, progressive paraparesis
with spasticity, absent reflexes, ataxia, incontinence, and
paresthesias [13]. In the 14 toxoplasmosis cases with spinal
cord involvement reviewed by Vyas and Ebright, they found
the most common presentations of acute or sub-acute
symptoms were paraparesis, urine retention, sensory level
deficits, fever, and local pain. CSF cytology showed increased
protein-level elevation and a CD4 count of less than 50/mm
3.
In the patients evaluated by spinal cord MRI imaging,
localized intramedullary lesions or spinal cord edema were
found in more than 90% of cases associated with positive T.
gondii IgG antibody [3]. No cases of associated transverse
myelitis, as in this case, were described. In our case, diagnosis
was based on the clinical picture and response to therapy.
Evaluation in a symptomatic patient should include serum
and CSF cytology and antibody (immunological) studies as
they remain the gold standard for identifying an infectious
agent. Complete radiographic imaging of the entire neuroaxis
[3, 15] is key in clearly defining inflammatory lesions of the
brain and spine, and in the visualization of typical lesions that
allow for rapid diagnosis. This helps determine whether the
lesion is extramedullary or an intrinsic spinal cord disease,
which in turn provides information to determine whether
surgical or medical therapy is needed [3]. In opportunistic
diseases, the imaging studies also have a crucial role in
diagnosis and monitoring of the therapeutic response [8].
Neuroimaging findings, along with other clues, help to
narrow the differential diagnosis. On an MRI, findings of a
normal-sized spinal cord but with an abnormal signal should
signal the possibility of vacuolar myelopathy and ADC-related
HIV myelitis. Lesions of viral myelitis can potentially cause
spinal cord enlargement; however, laboratorydata are required
for confirmation [3]. If spinal cord enlargement is present,
toxoplasma myelitis and lymphoma should be strongly
considered [14]. Lymphoma has been associated with positive
CSF polymerase chain reaction (PCR) for Epstein-Barr virus
[9]. If both spinal cord enlargement and an abnormal signal
are associated with meningeal enhancement, then CMV, M.
tuberculosis, lymphoma, and toxoplasmosis should be con-
sidered along with other less likely infectious causes [3].
MRI (plain and contrast-enhanced) is currently considered
appropriately sensitive for detecting brain and spinal cord
lesions; however, equal sensitivity has been reported using
delayed-contrast CT scanning [1]. The current guidelines for
diagnosis of intracranial lesions state that T1 SPECT is an
option when available. When positive (marked uptake in
contrast to toxoplasma), it appears to be highly specific for
primary CNS lymphoma [6, 8]. These guidelines have been
described as helpful [3] in spinal cord lesions and suspected
lymphoma, although specific guidelines for spinal cord lesions
are not presently available. The newer and more available
MRI techniques of diffusion-weighted imaging (DWI) may be
of help in the differentiation of lymphoma, showing no
restriction in water diffusion [8]. If a diagnosis of solitary or
atypical lesions cannot be made with noninvasive methods, a
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with concomitant negative toxoplasmosis serology since a
negative serology does not exclude diagnosis of toxoplasmo-
sis nor differentiate from lymphoma. A biopsy may also be
considered necessary if a patient experiences a rapid decline in
function or, alternately, fails to improve despite therapy [1].
Brain biopsies have been associated with hemorrhage
risk and an increased mortality (2%) and morbidity rate
(12%) in patients with HIV/AIDS. The estimated rate of
non-diagnostic brain biopsies ranges between 4–36% [6].
Empiric treatment for toxoplasmosis with oral pyrimeth-
amine and sulfadiazine (with folinic acid) has been recom-
mendedinallcasesofintracranialmasslesionsinpatientswith
HIV/AIDS(exceptinasolitarymasswithnegativetoxoplasma
serology) [6]. It is also believed to be beneficial when there is
spinal cord involvement [2]. Steroids promote radiological
improvement in about 80% of patients, and improvement can
be seen in about 1 week, supporting the diagnosis [8].
Patients are usually monitored clinically and radiographically
for response to treatment over a 10- to 14-day period
following empiric therapy. If responsive, anti-toxoplasmosis
therapy is continued indefinitely, and reevaluation in the
absence of steroid treatment is mandated. If the lesions
remain unchanged or progress, the diagnosis has to be
reconsidered and the therapeutic strategy reevaluated. In
cases of atypical large solitary toxoplasma lesions resembling
lymphoma (that also present with spinal cord enlargement),
additional diagnostic modalities should be performed [3, 6].
Due to the immunosuppressant effects of steroids [9], the
optimal dosage and period of treatment for spinal cord lesions
must be addressed in future studies.
In this case, the brain and spinal cord lesions were found
in an HIV-positive man who had not previously been
diagnosed. For this reason, other causes of CNS infection
and lymphoma were first considered. After the positive
serology, empiric treatment for cerebral toxoplasmosis was
initiated. The patient’s clinical and radiographic improve-
ment led to the final diagnosis of toxoplasmic myelitis and
encephalitis, similar to other cases documented in the
literature by Vyas et al. in 1996 [4].
Acute myelopathy was one of the first manifestations of
AIDS in this patient. Many patients with neurological disease
are unaware of their HIV status. Furthermore, toxoplasmic
myelopathy has been described in patients without HIV, albeit
with severe immunosuppression [2, 3, 11, 12] ,a n di np a t i e n t s
with isolated spinal cord lesions [1, 2, 11]. New neurological
deficit in any patient should raise a high index of suspicion of
HIV infection. Appropriate diagnostic methods and manage-
ment that are practical for all settings, including those with
limited technologies, should be sought. Newer methods of
diagnosis and management for all neurological complications
of HIV should be addressed. An algorithm for the evaluation
and management of spinal cord lesions should be established
[4]. We established ours based on the clinical manifestations,
history, and general improvement of the patient's condition.
Although spinal cord toxoplasmosis is uncommon, it
has been suggested that most patients with AIDS that
present with evolving myelopathy, characterized by
extremity weakness, sensory involvement, spinal cord
enlargement, and enhancing lesions in brain or spinal
cord CT or MRI, have toxoplasmic myelitis [3, 5]. The
likelihood of diagnosis increases if serum titers for
Toxoplasma antibodies are positive or where the initiation
of early treatment with empiric anti-toxoplasmosis therapy
and steroids improves both the patient’s clinical and
radiographic manifestations.
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